Research Leading to Ozempic Honored by 2024 Lasker Awards
WEB1 day ago · Research That Led to Obesity Drugs Wins Major Medical Prize. Three scientists were recognized by the Lasker Awards for their work on the GLP-1 hormone. Others were honored for work to stop H.I.V ...
Harvard Medical School Researcher Wins 2024 Lasker Award for …
WEB17 hours ago · Harvard Medical School researcher Joel Habener has won the 2024 Lasker~DeBakey Clinical Medical Research Award for his discovery of glucagon-like peptide-1 (GLP-1), a molecule that has become the basis for therapies which have transformed the treatment of obesity.Lasker awards, sometimes called “America’s Nobels,” are among the world’s most prestigious biomedical and clinical research ...
GLP-1-based therapy for obesity - Lasker Foundation
WEBThe 2024 Lasker~DeBakey Clinical Medical Research Award honors three scientists for their discovery and development of GLP-1-based drugs that have revolutionized the treatment of obesity.Joel Habener (Massachusetts General Hospital) and Svetlana Mojsov (The Rockefeller University) discerned the physiologically active form of the hormone, and Lotte Bjerre Knudsen (Novo Nordisk) turned it into ...
Long-overlooked scientist shares Lasker Award with other GLP-1 …
WEB17 hours ago · Sept. 19, 2024. GLP-1 based drugs are transforming the treatment of obesity and opening up new avenues for addressing heart disease, addiction, and even Alzheimer’s. Now, three scientists who ...
Discovery of GLP-1–Based Drugs for the Treatment of Obesity
WEB17 hours ago · The 2024 Lasker–DeBakey Clinical Medical Research Award recognizes Drs. Habener, Mojsov, and Knudsen, who developed GLP-1 medicines that have revolutionized the treatment of obesity.
Obesity-Drug Pioneers Win Prestigious Lasker Award for Medical …
WEB12 hours ago · The trio, recognized with a Lasker in the clinical-research category, will share a US$250,000 prize. Biomedical scientists are enthusiastic about the increasing recognition of GLP-1 research ...
Chemistry Matters—From a Putative Peptide to Effective …
WEB1 day ago · In this Viewpoint, 2024 Lasker-DeBakey Clinical Medical Research Award winner Svetlana Mojsov describes her discovery of GLP-1 (7-37), the biologically active incretin that led to development of effective GLP-1 …
The 2024 Lasker Awards - The Lancet
WEB6 hours ago · The 2024 Lasker Awards. This year's recipients have been recognised for their work on the HIV epidemic, GLP-1-based drugs, and how DNA can stimulate immune and inflammatory responses. Talha Burki reports. On Sept 19, 2024, the Albert and Mary Lasker Foundation announced the winners of its annual awards in biomedical science.
GLP-1 for Treating Obesity: 2024 Lasker-DeBakey Clinical Medical ...
WEB1 day ago · GLP-1RAs mediate their effects through the multifaceted biology that comes with GLP-1 receptor expression in specific cells in many organs of the body. 7 Clinical studies have documented a wide range of benefits, from cardiovascular and kidney risk reduction to improved functional outcomes in heart failure with preserved ejection fraction ...
Joel Habener receives 2024 Lasker Award - Harvard Medical School
WEB1 day ago · Dear Members of the HMS and HSDM Community:I am delighted to share that HMS physician-scientist Joel Habener has been named co-recipient of the 2024 Lasker–DeBakey Clinical Medical Research Award. Joel is being honored for his discovery of glucagon-like peptide-1 (GLP-1), a molecule that became the basis for GLP-1 therapies that have revolutionized the treatment of type 2 diabetes and obesity.
- Some results have been removed